Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: a systematic review
Julian Hirt, Perrine Janiaud, Viktoria Gloy, Stefan Schandelmaier, Tiago Pereira, Despina G. Contopoulos‐Ioannidis, Steven N. Goodman, John P A Ioannidis, Klaus Munkholm, Lars G. Hemkens (2022). Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: a systematic review. , 108(6), DOI: https://doi.org/10.1136/archdischild-2022-324455.
Article34 days agoValidity of reported post-acute health outcomes in children with SARS-CoV-2 infection: a systematic review
Julian Hirt, Perrine Janiaud, Viktoria Gloy, Stefan Schandelmaier, Tiago Pereira, Despina G. Contopoulos‐Ioannidis, Steven N. Goodman, John P A Ioannidis, Klaus Munkholm, Lars G. Hemkens (2022). Validity of reported post-acute health outcomes in children with SARS-CoV-2 infection: a systematic review. , DOI: https://doi.org/10.1101/2022.03.18.22272582.
Article34 days agoClinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016
Aviv Ladanie, Andreas M. Schmitt, Benjamin Speich, Florian Naudet, Arnav Agarwal, Tiago Pereira, Francesco Sclafani, Amanda K. Herbrand, Matthias Briel, Juan Martín-Liberal, Thomas Schmid, Hannah Ewald, John P A Ioannidis, Heiner C. Bucher, Benjamin Kasenda, Lars G. Hemkens (2020). Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016. , 3(11), DOI: https://doi.org/10.1001/jamanetworkopen.2020.24406.
Article34 days agoSingle pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies
Aviv Ladanie, Benjamin Speich, Matthias Briel, Francesco Sclafani, Heiner C. Bucher, Arnav Agarwal, John P A Ioannidis, Tiago Pereira, Benjamin Kasenda, Lars G. Hemkens (2019). Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies. , 114, DOI: https://doi.org/10.1016/j.jclinepi.2019.05.033.
Article34 days agoThe Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs
Aviv Ladanie, Benjamin Speich, Florian Naudet, Arnav Agarwal, Tiago Pereira, Francesco Sclafani, Juan Martín-Liberal, Thomas Schmid, Hannah Ewald, John P A Ioannidis, Heiner C. Bucher, Benjamin Kasenda, Lars G. Hemkens (2018). The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs. , 19(1), DOI: https://doi.org/10.1186/s13063-018-2877-z.
Article34 days ago